Wanda Biopharmaceuticals' stock price rose by 2.3% in pre-market trading after the U.S. Food and Drug Administration officially accepted the company's review application for a rare skin disease drug.
Show original
This development marks a key step forward for the drug in the regulatory approval process, laying the foundation for potential future market access.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$66,602.89
-0.69%
Ethereum
ETH
$1,968.57
-1.75%
Tether USDt
USDT
$1
-0.01%
BNB
BNB
$622.48
-0.58%
XRP
XRP
$1.36
-2.68%
USDC
USDC
$1.0000
-0.01%
Solana
SOL
$83.96
-3.13%
TRON
TRX
$0.2813
-0.36%
Dogecoin
DOGE
$0.09282
-2.44%
Cardano
ADA
$0.2740
-3.37%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now